Results of a clinical trial of H3B-8800, a splicing modulator, in patients with myelodysplastic syndromes (MDS), acute myeloid leukemia (AML) or chronic myelomonocytic leukemia (CMML) Meeting Abstract


Authors: Steensma, D. P.; Wermke, M.; Klimek, V. M.; Greenberg, P. L.; Font, P.; Komrokji, R. S.; Yang, J.; Brunner, A. M.; Carraway, H. E.; Ades, L.; Al-Kali, A.; Dominguez, J. M. A.; Alonso, A.; Coombs, C. C.; Deeg, H. J.; Donnellan, W. B.; Foran, J. M.; Garcia-Manero, G.; Maris, M. B.; McMasters, M.; Micol, J. B.; De Oteyza, J. P.; Thol, F.; Wang, E. S.; Watts, J. M.; Buonamici, S.; Kim, A.; Gourineni, V.; Marino, A. J.; Rioux, N.; Schindler, J.; Smith, S.; Yao, H.; Yuan, X.; Yu, K.; Platzbecker, U.
Abstract Title: Results of a clinical trial of H3B-8800, a splicing modulator, in patients with myelodysplastic syndromes (MDS), acute myeloid leukemia (AML) or chronic myelomonocytic leukemia (CMML)
Meeting Title: 61st Annual Meeting and Exposition of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 134
Issue: Suppl. 1
Meeting Dates: 2019 Dec 7-10
Meeting Location: Orlando, FL
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2019-11-13
Language: English
ACCESSION: WOS:000518218500689
DOI: 10.1182/blood-2019-123854
PROVIDER: wos
Notes: Meeting Abstract: 673 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Virginia Klimek
    147 Klimek
Related MSK Work